Arrowhead's subsidiary Visirna has entered an agreement with Sanofi for plozasiran, a potential treatment for hypertriglyceridemia.

President Donald Trump's warnings about pharmaceutical tariffs have triggered a wave of manufacturing commitments from major ...

The Centre has made it mandatory to print QR codes on the packaging of the top 300 drug brands that sell medicines in India.

A 492-strong Cardiff-based pharmaceutical firm has posted a fall in turnover and profits in its latest year amid a decrease ...

Evidence-based medicine "Boy Wonder" Dr. Vinay Prasad was fired as CBER Director after less than three months on the job.

Europe’s cannabis pharmaceutical sector is shifting as scientific rigour, regulatory clarity and cautious capital define its next chapter.

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...

Marcus Evans announces the PharmaPack Summit 2025, an invitation-only event dedicated to the leaders defining the future of pharmaceutical packaging.

Pfizer's oncology pipeline looks promising. The company's newer approvals could make significant progress. And its efforts to ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

If you're looking to put cash into two fantastic biotech stocks that Wall Street seems particularly bullish on, there's one ...

In a sweeping move to eliminate mercury exposure from vaccines, U.S. Department of Health and Human Services Secretary Robert ...